23 January 2024
A pharmaceutical cluster is being planned for the Stavropol Territory, with the aim of attracting funding from international partners. It is anticipated that India will take an interest in the collaboration, and the regional government is actively pursuing this opportunity. However, negotiations with potential partners have not yielded outcomes, as revealed during a press conference featuring the regional governor, Vladimir Vladimirov.
“We are holding extensive negotiations with the Indian company. <…> They have not ended in anything yet, but I will explain why pharmaceutical medicine, except for active biological products, is interesting to us, because it is a high-tech industry,” he said, clarifying that one Indian company intends to produce pharmaceutical substances on the basis of the Stavropol site.
Despite the fact that there is no agreement with any Indian company yet, the government will not abandon this project, he promised. And he added that the initiative to create a pharmaceutical cluster meets the interests of the region, including because the Pyatigorsk Medical and Pharmaceutical Institute is located here.
“The potential of our Pyatigorsk Pharmaceutical Academy allows us to argue that we can place such a project on the territory of the Stavropol Territory,” the official said.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024